Jul. 14 at 1:26 PM
$TMDX Not hating on technicals as we saw the bloodbath in November thru January. Just feels like the TMDX story is much easier now with flights and strong commentary.
Manipulation happens, but over the long term range, I've always seen us as above
$500/share. Could see above
$200 this year and above
$300 next.
Once the next generation product comes online and they start storing organs for 3-7 days we'll see a right sizing in supply demand and more physicians will start saying, "that liver sucks, let's get ahead of it..." and bam, you get a new one, demand creation. This is 2029 and beyond activity. We will be
$1,500+ a share, 10 years at most. There's nothing that will replicate a human organ. 3D printing won't work and no one will agree to a trial once next generation products are unleashed.
